ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million

July 6, 1990

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003

Clanton Resigns From NCI.

January 12, 2007

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Tobacco Industry Walkout Unlikely To Imperil Legislation

April 17, 1998